pteridines has been researched along with Obesity in 3 studies
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "This review of literature and our data suggests that up-regulated production of interferon-gamma (IFNG) in periphery and brain triggers a merger of tryptophan (TRY)-kynurenine (KYN) and guanine-tetrahydrobiopterin (BH4) metabolic pathways into inflammation cascade involved in aging and aging-associated medical and psychiatric disorders (AAMPD) (metabolic syndrome, depression, vascular cognitive impairment)." | 7.77 | Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders. ( Oxenkrug, GF, 2011) |
| "Hence, abdominal obesity is associated with vascular endothelial dysfunction and reduced nitric oxide (NO) availability." | 6.55 | The Interactions Between Kynurenine, Folate, Methionine and Pteridine Pathways in Obesity. ( Engin, A; Engin, AB, 2017) |
| "This review of literature and our data suggests that up-regulated production of interferon-gamma (IFNG) in periphery and brain triggers a merger of tryptophan (TRY)-kynurenine (KYN) and guanine-tetrahydrobiopterin (BH4) metabolic pathways into inflammation cascade involved in aging and aging-associated medical and psychiatric disorders (AAMPD) (metabolic syndrome, depression, vascular cognitive impairment)." | 3.77 | Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders. ( Oxenkrug, GF, 2011) |
| "Hence, abdominal obesity is associated with vascular endothelial dysfunction and reduced nitric oxide (NO) availability." | 2.55 | The Interactions Between Kynurenine, Folate, Methionine and Pteridine Pathways in Obesity. ( Engin, A; Engin, AB, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engin, AB | 1 |
| Engin, A | 1 |
| Oxenkrug, GF | 1 |
| Jenny, M | 1 |
1 review available for pteridines and Obesity
| Article | Year |
|---|---|
The Interactions Between Kynurenine, Folate, Methionine and Pteridine Pathways in Obesity.
Topics: Animals; Folic Acid; Humans; Inflammation; Kynurenine; Methionine; Obesity; Pteridines; Signal Trans | 2017 |
2 other studies available for pteridines and Obesity
| Article | Year |
|---|---|
Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders.
Topics: Aging; Animals; Humans; Inflammation; Interferon-gamma; Kynurenine; Mental Disorders; Metabolic Synd | 2011 |
[Study of the new diuretic: Amiloride (MK-870)].
Topics: Aged; Ascites; Body Weight; Diuresis; Diuretics; Edema; Female; Heart Failure; Humans; Liver Cirrhos | 1969 |